Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway

Oncogene

Volumn 33, Issue 38, 2014, Pages 4675-4684

  Lee, I H ^a   Sohn, M ^a   Lim, H J ^a   Yoon, S ^a   Oh, H ^a   Shin, S ^a   Shin, J H ^b   Oh, S H ^c   Kim, J ^a   Lee, D K ^a   Noh, D Y ^b   Bae, D S ^d   Seong, J K ^b   Bae, Y S ^a  

^a Ewha Womans University   (South Korea)

^b Seoul National University   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AHNAK PROTEIN, MOUSE; MEMBRANE PROTEIN; PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

3T3 CELL LINE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CANCER TRANSPLANTATION; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; FEMALE; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; NUDE MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NIH 3T3 CELLS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEINS;

EID: 84896421792     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.69     Document Type: Article

References (35)

1. Shtivelman E, Cohen FE, Bishop JM. A human gene (AHNAK) encoding an unusually large protein with a 1. 2-microns polyionic rod structure. Proc Natl Acad Sci USA 1992; 89: 5472-5476.
2. Shtivelman E, Bishop JM. The human gene AHNAK encodes a large phosphoprotein located primarily in the nucleus. J Cell Biol 1993; 120: 625-630.
3. Hashimoto T, Gamou S, Shimizu N, Kitajima Y, Nishikawa T. Regulation of translocation of the desmoyokin/AHNAK protein to the plasma membrane in keratinocytes by protein kinase C. Exp Cell Res 1995; 217: 258-266.
4. Hohaus A, Person V, Behlke J, Schaper J, Morano I, Haase H. The carboxyl-terminal region of ahnak provides a link between cardiac L-type Ca2+ channels and the actin-based cytoskeleton. FASEB J 2002; 16: 1205-1216.
5. Haase H, Podzuweit T, Lutsch G, Hohaus A, Kostka S, Lindschau C et al. Signaling from beta-adrenoceptor to L-type calcium channel: identification of a novel cardiac protein kinase A target possessing similarities to AHNAK. FASEB J 1999; 13: 2161-2172.
6. Gentil BJ, Delphin C, Mbele GO, Deloulme JC, Ferro M, Garin J et al. The giant protein AHNAK is a specific target for the calcium-and zinc-binding S100B protein: potential implications for Ca2+ homeostasis regulation by S100B. J Biol Chem 2001; 276: 23253-23261.
7. Sekiya F, Bae YS, Jhon DY, Hwang SC, Rhee SG. AHNAK, a protein that binds and activates phospholipase C-gamma1 in the presence of arachidonic acid. J Biol Chem 1999; 274: 13900-13907.
8. Lee IH, You JO, Ha KS, Bae DS, Suh PG, Rhee SG et al. AHNAK-mediated activation of phospholipase C-gamma1 through protein kinase C. J Biol Chem 2004; 279: 26645-26653.
9. Lee IH, Lim HJ, Yoon S, Seong JK, Bae DS, Rhee SG et al. Ahnak protein activates protein kinase C (PKC) through dissociation of the PKC-protein phosphatase 2A complex. J Biol Chem 2008; 283: 6312-6320.
10. Lim HJ, Kang DH, Lim JM, Kang DM, Seong JK, Kang SW et al. Function of Ahnak protein in aortic smooth muscle cell migration through Rac activation. Cardiovasc Res 2013; 97: 302-310.
11. Pelengaris S, Khan M, Evan GI. Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 2002; 109: 321-334.
12. Massague J. TGFbeta in cancer. Cell 2008; 134: 215-230.
13. Massague J. TGFbeta signalling in context. Nat Rev Mol Cell Biol 2012; 13: 616-630.
14. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-1512.
15. Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y et al. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol 2007; 27: 4488-4499.
16. Kang JS, Liu C, Derynck R. New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol 2009; 19: 385-394.
17. Heldin CH, Moustakas A. Role of Smads in TGFbeta signaling. Cell Tissue Res 2012; 347: 21-36.
18. Florenes VA, Bhattacharya N, Bani MR, Ben-David Y, Kerbel RS, Slingerland JM. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1. Oncogene 1996; 13: 2447-2457.
19. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 2003; 13: 65-70.
20. Sherr CJ. Principles of tumor suppression. Cell 2004; 116: 235-246.
21. Seedorf K, Oltersdorf T, Krammer G, Rowekamp W. Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells. EMBO J 1987; 6: 139-144.
22. Jackson R, Togtema M, Zehbe I. Subcellular localization and quantitation of the human papillomavirus type 16 E6 oncoprotein through immunocytochemistry detection. Virology 2013; 435: 425-432.
23. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992; 12: 954-961.
24. Briones-Orta MA, Tecalco-Cruz AC, Sosa-Garrocho M, Caligaris C, Macias-Silva M. Inhibitory Smad7: emerging roles in health and disease. Curr Mol Pharmacol 2011; 4: 141-153.
25. Conidi A, Cazzola S, Beets K, Coddens K, Collart C, Cornelis F et al. Few Smad proteins and many Smad-interacting proteins yield multiple functions and action modes in TGFbeta/BMP signaling in vivo. Cytokine Growth Factor Rev 2011; 22: 287-300.
26. Morikawa M, Koinuma D, Miyazono K, Heldin CH. Genome-wide mechanisms of Smad binding. Oncogene 2012; 32: 1609-1615.
27. Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J et al. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell 2006; 125: 915-928.
28. Wang C, Lisanti MP, Liao DJ. Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology. Cell Cycle 2011; 10: 57-67.
29. Zuber J, Tchernitsa OI, Hinzmann B, Schmitz AC, Grips M, Hellriegel M et al. A genome-wide survey of RAS transformation targets. Nat Genet 2000; 24: 144-152.
30. Forrester E, Chytil A, Bierie B, Aakre M, Gorska AE, Sharif-Afshar AR et al. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res 2005; 65: 2296-2302.
31. Drabsch Y, ten Dijke P. TGF-beta signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev 2012; 31: 553-568.
32. Tarasewicz E, Jeruss JS. Phospho-specific Smad3 signaling: impact on breast oncogenesis. Cell Cycle 2012; 11: 2443-2451.
33. Sundqvist A, Ten Dijke P, van Dam H. Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity. Breast Cancer Res 2012; 14: 204.
34. Scollen S, Luccarini C, Baynes C, Driver K, Humphreys MK, Garcia-Closas M et al. TGF-beta signaling pathway and breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2011; 20: 1112-1119.
35. Heldin CH, Landstrom M, Moustakas A. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 2009; 21: 166-176.